AUGMENTIN is an oral antibacterial combination consisting of the semisynthetic antibiotic amoxicillin and the β-lactamase inhibitor, clavulanate potassium (the potassium salt of...
Augmentin: Package Insert - Drugs.com
2024年3月25日 · Augmentin package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Augmentin XR: Package Insert - Drugs.com
2024年3月25日 · AUGMENTIN XR Extended Release Tablets are indicated for the treatment of patients with community-acquired pneumonia or acute bacterial sinusitis due to confirmed, or suspected β-lactamase–producing pathogens (i.e., H. influenzae, M. catarrhalis, H. parainfluenzae, K. pneumoniae, or methicillin-susceptible S. aureus) and S. pneumoniae with ...
AUGMENTIN (amoxicillin/clavulanate potassium) and other antibacterial drugs, AUGMENTIN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by...
DailyMed - AUGMENTINXR- amoxicillin and clavulanate …
2010年11月22日 · AUGMENTIN XR Extended Release Tablets are indicated for the treatment of patients with community-acquired pneumonia or acute bacterial sinusitis due to confirmed, or suspected β-lactamase−producing pathogens (i.e., H. influenzae, M. catarrhalis, H. parainfluenzae, K. pneumoniae, or methicillin-susceptible S. aureus) and S. pneumoniae with ...
Augmentin Oral Suspension: Package Insert - Drugs.com
Augmentin Oral Suspension package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
DailyMed - AUGMENTIN ES-600- amoxicillin and clavulanate …
2012年12月3日 · AUGMENTIN ES-600 Powder for Oral Suspension is indicated for the treatment of pediatric patients with recurrent or persistent acute otitis media due to S. pneumoniae (penicillin MICs ≤ 2 mcg/mL), H. influenzae (including β-lactamase–producing strains), or M. catarrhalis (including β-lactamase–producing strains) characterized by the ...
Augmentin (Allegis Pharmaceuticals, LLC): FDA Package Insert
2023年3月21日 · AUGMENTIN is indicated for the treatment of infections in adults and pediatric patients, due to susceptible isolates of the designated bacteria in the conditions listed below: Lower Respiratory Tract Infections — caused by beta‑lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis.
AUGMENTIN is an oral antibacterial combination consisting of the semisynthetic antibiotic amoxicillin and the β-lactamase inhibitor, clavulanate potassium (the potassium salt of clavulanic...
AUGMENTIN suspension (228 mg/5 mL and 457 mg/5 mL), for twice daily oral dosing, is indicated for short term treatment of bacterial infections at the following sites when amoxicillin resistant beta-lactamase producing strains are suspected as the cause.